Current and future use of aminodihydrophthalazindione sodium in patients with COVID-19, including for «cytokine storm» therapy
Open Access
- 28 October 2020
- journal article
- Published by Publishing House OKI in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
- No. 4S,p. 4-7
- https://doi.org/10.37489/2588-0519-2020-s4-4-7
Abstract
There are no data on the clinical efficacy of the preparation containing sodium aminodihydrophthalazindione in «cytokine storm», including in patients with COVID-19. Protocols of planned or ongoing clinical trials of a preparation containing sodium aminodihydrophthalazindione at COVID-19 have not been found. The use of sodium aminodihydrophthalazindione in the treatment of COVID-19 is possible only in clinical trials.Keywords
This publication has 4 references indexed in Scilit:
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Efficiency of immunomodulatotors for complex therapy of chronic recurrent cystitis in womenUrologiia, 2019
- Cytokine storm and sepsis disease pathogenesisSeminars in Immunopathology, 2017
- Performance Testing of Web Map Services tn three Dimensions – X, Y, ScaleSlovak Journal of Civil Engineering, 2013